# A Phase 1 Clinical Trial DHP2306R1 and DHP2306R2 in Healthy Adult Volunteers

> **NCT06395155** · PHASE1 · COMPLETED · sponsor: **Daehwa Pharmaceutical Co., Ltd.** · enrollment: 54 (actual)

## Conditions studied

- Musculoskeletal Pain

## Interventions

- **DRUG:** DHP2306R1
- **DRUG:** DHP2306R2

## Key facts

- **NCT ID:** NCT06395155
- **Lead sponsor:** Daehwa Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-26
- **Primary completion:** 2023-12-07
- **Final completion:** 2023-12-07
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06395155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06395155, "A Phase 1 Clinical Trial DHP2306R1 and DHP2306R2 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06395155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*